NY S04532

Prohibits prior authorization requirements for opioid medications from requiring patients to first use non-abuse-deterrent opioids before accessing abuse-deterrent opioid products.

Mandates insurance carriers and health plans cover at least one abuse-deterrent opioid analgesic drug product per active opioid ingredient on their formularies.

Restricts cost-sharing for brand name abuse-deterrent opioids to not exceed the lowest cost-sharing level applied to brand name non-abuse-deterrent opioids under the same plan.

Restricts cost-sharing for generic abuse-deterrent opioids to not exceed the lowest cost-sharing level applied to generic non-abuse-deterrent opioids under the same plan.

Prohibits increases in patient cost-sharing or disincentives for prescribers and dispensers to achieve compliance with these coverage requirements.

Takes effect 120 days after becoming law and applies to all policies and contracts issued, renewed, modified, altered or amended on or after that date.